Boryeong Mucomist Liquid (Acetylcysteine)
Acetylcysteine 20g
OTC medication
Boryeong Co., Ltd.
MFDS item code 198700683 · Notified 1987.03.18 · Insurance code 641901241
Treatment for difficulty expectorating sputum and for procedures before and after examinations or surgery
This medication is used when sputum excretion is difficult in conditions such as bronchial asthma, chronic bronchitis, bronchiectasis, pulmonary tuberculosis, emphysema, upper respiratory tract inflammation, pulmonary abscess, pneumonia, and cystic fibrosis. It also aids in procedures before and after bronchography, bronchoscopy, lung cancer cytology tests, and tracheostomy. By promoting the secretion of mucus in the airways, this medication makes breathing more comfortable and facilitates treatment and tests, ultimately improving the patient's respiratory condition.
This medicine may be diluted to a lower concentration using Sodium Chloride Injection, Sodium Chloride Inhalation Solution, Sterile Water for Injection, or Sterile Water for Inhalation. 1. Nebulization using a face mask, mouthpiece, or tracheostomy: Nebulize 1 ~ 10 mL of this medicine every 2 ~ 6 hours. The recommended dose is 3~ 5 mL nebulized 3 ~ 4 times daily. 2. Nebulization using a tent or inhaler (Croupette): This method is used when required in special cases, and is selected individually according to the patient's needs and the convenience of administration. This method requires a large volume of solution, sometimes up to approximately 300 mL for a single treatment. The recommended amount should be sufficient to maintain a very dense, mist-like atmosphere in the tent or inhaler throughout the treatment period. Intermittent or continuous administration over a prolonged period is desirable. 3. For direct instillation 1) Administer 1 ~ 2 mL of this medicine every hour. 2) For routine treatment of patients who have undergone tracheostomy, administer 1 ~ 2 mL of this medicine through the tracheostomy every 1 ~ 4 hours. 3) When administering directly to a specific part of the bronchial tree by inserting a small plastic catheter into the trachea under local anesthesia and through a direct incision, administer 2 ~ 5 mL of this medicine every 1 ~ 4 hours using a syringe connected to the catheter. 4) When administering via a percutaneous intrabronchial catheter, administer 1 ~ 2 mL of this medicine every 1 ~ 4 hours using a syringe connected to the catheter. 4. For diagnostic bronchography Before performing bronchography, administer 1 ~ 2 mL of this medicine 2 ~ 3 times by nebulization or intrabronchial instillation.
This medication should not be taken by individuals who are allergic to this drug or its components. Patients with ulcers in the stomach or duodenum and infants under 2 years old should also avoid using this medication. Women who are pregnant or may become pregnant must consult a doctor before taking this medication and should only use it when absolutely necessary. Breastfeeding women should also exercise caution due to uncertainty about whether this medication is excreted in breast milk. If digestive symptoms such as nausea, vomiting, mouth inflammation, heartburn, or diarrhea occur during use, or if allergic symptoms such as hives, itching, rash, headache, tinnitus, or bronchospasm develop, immediate discontinuation and consultation with a healthcare professional is required. When taking this medication, antibiotics should be administered at least 2 hours apart, as simultaneous use may reduce the effect of the antibiotics. Avoid mixing other drugs with this medication solution, and store the medication out of reach of children and in its original container to maintain quality. For use as an inhalant, patients with bronchial asthma or reduced respiratory function must consult a healthcare professional beforehand, and if symptoms such as difficulty breathing or allergic reactions occur during use, immediate discontinuation is necessary. Caution is required for elderly patients and children as safety has not been fully established. After inhalation, if a mask is tightly affixed to the face, it can be easily removed with water wash. Inhalation devices should be cleaned immediately after use, and avoid combined use with other medications. This medication should not be used as an injection or eye drop, and for nebulization, it is safe to dilute to prevent the drug concentration from becoming excessively thick.
Not everyone experiences these, and they can vary from person to person.
This medication should be inhaled separately or injected or taken orally when combined with antibiotics.
This medication should be stored in a tightly sealed container to avoid exposure to air or light, and it is best stored at room temperature. This will help maintain the effectiveness of the medication.
A colorless, transparent liquid with a slight peculiar smell.
4mL/bottle x 10
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Acetylcysteine 20g
OTC medication
Boryeong Co., Ltd.
Acetylcysteine 200mg
Solution · OTC medication
(Co., Ltd.) Celltrion Pharm
Acetylcysteine 200mg
OTC medication
Hanwha Pharmaceutical Co., Ltd.

Acetylcysteine 200mg
Hard capsule · OTC medication
Hanwha Pharmaceutical Co., Ltd.

Acetylcysteine 100mg
Hard capsule · OTC medication
Hanwha Pharmaceutical Co., Ltd.

Acetylcysteine 200mg
Hard capsule · OTC medication
(Medica Korea Co., Ltd.)

Acetylcysteine 200mg
Hard capsule · OTC medication
Alpha Pharmaceutical Co., Ltd.

Acetylcysteine 200mg
Hard capsule · OTC medication
Donggwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.